Faculty, Staff and Student Publications
Publication Date
10-7-2022
Journal
Morbidity and Mortality Weekly Report
Abstract
The New Vaccine Surveillance Network (NVSN) is a prospective, active, population-based surveillance platform that enrolls children with acute respiratory illnesses (ARIs) at seven pediatric medical centers. ARIs are caused by respiratory viruses including influenza virus, respiratory syncytial virus (RSV), human metapneumovirus (HMPV), human parainfluenza viruses (HPIVs), and most recently SARS-CoV-2 (the virus that causes COVID-19), which result in morbidity among infants and young children (1-6). NVSN estimates the incidence of pathogen-specific pediatric ARIs and collects clinical data (e.g., underlying medical conditions and vaccination status) to assess risk factors for severe disease and calculate influenza and COVID-19 vaccine effectiveness. Current NVSN inpatient (i.e., hospital) surveillance began in 2015, expanded to emergency departments (EDs) in 2016, and to outpatient clinics in 2018. This report describes demographic characteristics of enrolled children who received care in these settings, and yearly circulation of influenza, RSV, HMPV, HPIV1-3, adenovirus, human rhinovirus and enterovirus (RV/EV),* and SARS-CoV-2 during December 2016-August 2021. Among 90,085 eligible infants, children, and adolescents (children) aged <18 >years
Keywords
Adolescent, Antibodies, Monoclonal, COVID-19, COVID-19 Vaccines, Child, Child, Preschool, Humans, Infant, Influenza, Human, Metapneumovirus, Prospective Studies, Respiratory Syncytial Virus, Human, Respiratory Tract Infections, SARS-CoV-2, United States, Viruses
Included in
COVID-19 Commons, Internal Medicine Commons, Maternal and Child Health Commons, Maternal, Child Health and Neonatal Nursing Commons